accountDurham-based drug developer Icagen Inc. on Wednesday reported a net loss of nearly...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Icagen 2Q net loss increases
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account